These findings may explain our recent observation that perturbations in the relative abundance of FGF2 and NUDT6 mRNAs was a significant prognostic indicator of disease outcome in esophageal adenocarcinoma [15], and suggest the potential for clinically relevant antisense-based therapeutic strategies for modulation of tumor progression. This evidence concerns the gene NUDT6 and esophageal adenocarcinoma.